217 related articles for article (PubMed ID: 28935460)
1. Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - Relationship with biochemical and echocardiography parameters.
Hromádka M; Seidlerová J; Suchý D; Rajdl D; Lhotský J; Ludvík J; Rokyta R; Baxa J
Int J Cardiol; 2017 Dec; 249():448-453. PubMed ID: 28935460
[TBL] [Abstract][Full Text] [Related]
2. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
[TBL] [Abstract][Full Text] [Related]
3. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.
Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A
Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging With T1 Mapping to Assess Myocardial Perfusion and Fibrosis in Systemic Sclerosis: Association With Cardiac Events From a Prospective Cohort Study.
Terrier B; Dechartres A; Gouya H; Ben Arfi M; Bérézne A; Régent A; Dunogué B; London J; Cohen P; Guillevin L; Le Jeunne C; Legmann P; Vignaux O; Mouthon L
Arthritis Rheumatol; 2020 Sep; 72(9):1571-1580. PubMed ID: 32379399
[TBL] [Abstract][Full Text] [Related]
5. T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.
Poindron V; Chatelus E; Canuet M; Gottenberg JE; Arnaud L; Gangi A; Gavand PE; Guffroy A; Korganow AS; Germain P; Sibilia J; El Ghannudi S; Martin T
Semin Arthritis Rheum; 2020 Feb; 50(1):128-134. PubMed ID: 31301817
[TBL] [Abstract][Full Text] [Related]
6. Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis.
Gotschy A; Jordan S; Stoeck CT; von Deuster C; Peer T; Gastl M; Vishnevskiy V; Wissmann L; Dobrota R; Mihai C; Becker MO; Maurer B; Kozerke S; Ruschitzka F; Distler O; Manka R
Eur Heart J Cardiovasc Imaging; 2023 Feb; 24(3):373-382. PubMed ID: 35639682
[TBL] [Abstract][Full Text] [Related]
7. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
8. Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor test.
Galea N; Rosato E; Gigante A; Borrazzo C; Fiorelli A; Barchetti G; Trombetta AC; Digiulio MA; Francone M; Catalano C; Carbone I
PLoS One; 2020; 15(12):e0244282. PubMed ID: 33351821
[TBL] [Abstract][Full Text] [Related]
9. Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis.
Lee DC; Hinchcliff ME; Sarnari R; Stark MM; Lee J; Koloms K; Hoffmann A; Carns M; Thakrar A; Aren K; Varga J; Aquino A; Carr JC; Benefield BC; Shah SJ
J Scleroderma Relat Disord; 2018 Jun; 3(2):159-169. PubMed ID: 29808171
[TBL] [Abstract][Full Text] [Related]
10. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
[TBL] [Abstract][Full Text] [Related]
11. Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis.
Dumitru RB; Bissell LA; Erhayiem B; Fent G; Kidambi A; Swoboda P; Abignano G; Donica H; Burska A; Greenwood JP; Biglands J; Del Galdo F; Plein S; Buch MH
Rheumatology (Oxford); 2021 Jun; 60(6):2934-2945. PubMed ID: 34080001
[TBL] [Abstract][Full Text] [Related]
12. Myocardial Involvement Detected Using Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis: A Prospective Observational Study.
Hromadka M; Baxa J; Seidlerova J; Miklik R; Rajdl D; Sudova V; Suchy D; Rokyta R
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830647
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
Dolan RS; Stillman AE; Davarpanah AH
Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
[TBL] [Abstract][Full Text] [Related]
14. Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference.
Foussier C; Barral PA; Jerosh-Herold M; Gariboldi V; Rapacchi S; Gallon A; Bartoli A; Bentatou Z; Guye M; Bernard M; Jacquier A
Diagn Interv Imaging; 2021 Mar; 102(3):163-169. PubMed ID: 32830084
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias.
Yiu KH; Schouffoer AA; Marsan NA; Ninaber MK; Stolk J; Vlieland TV; Scherptong RW; Delgado V; Holman ER; Tse HF; Huizinga TW; Bax JJ; Schuerwegh AJ
Arthritis Rheum; 2011 Dec; 63(12):3969-78. PubMed ID: 22127711
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study.
Tipparot T; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Pussadhamma B; Chaosuwannakit N
Int J Rheum Dis; 2019 Dec; 22(12):2125-2133. PubMed ID: 31659856
[TBL] [Abstract][Full Text] [Related]
17. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
18. Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosis.
Bordonaro V; Bivort D; Dresselaers T; De Langhe E; Bogaert J; Symons R
Clin Radiol; 2021 Feb; 76(2):162.e1-162.e8. PubMed ID: 33109349
[TBL] [Abstract][Full Text] [Related]
19. Native T1 mapping in early diffuse and limited systemic sclerosis, and its association with diastolic function.
Purevsuren M; Uehara M; Ishizuka M; Suzuki Y; Shimbo M; Kakuda N; Ishii S; Sumida H; Miyazaki M; Yamashita T; Yoshizaki A; Asano Y; Sato S; Hatano M; Komuro I
J Cardiol; 2023 Aug; 82(2):100-107. PubMed ID: 36921691
[TBL] [Abstract][Full Text] [Related]
20. Growth Differentiation Factor-15 (GDF-15) Level and Relation to Clinical Manifestations in Egyptian Systemic Sclerosis patients: Preliminary Data.
Gamal SM; Elgengehy FT; Kamal A; El Bakry SA; Shabaan E; Elgendy A; Bassyouni IH
Immunol Invest; 2017 Oct; 46(7):703-713. PubMed ID: 28872977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
